Toronto, Ontario – TheNewswire – October 10, 2023 – Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), an immune-oncology antibody-drug-conjugate company developing an innovative drug platform for the treatment of cancer
- 0 Comments
- FY2023
Toronto, Ontario – TheNewswire – October 10, 2023 – Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), an immune-oncology antibody-drug-conjugate company developing an innovative drug platform for the treatment of cancer